Literature DB >> 13584778

Figures and fancies.

S M LAIRD.   

Abstract

Keywords:  VENEREAL DISEASES/statistics

Mesh:

Year:  1958        PMID: 13584778      PMCID: PMC1047188          DOI: 10.1136/sti.34.3.137

Source DB:  PubMed          Journal:  Br J Vener Dis        ISSN: 0007-134X


× No keyword cloud information.
  2 in total

1.  Reiter's syndrome in first cousins.

Authors:  R S MORTON
Journal:  Br J Vener Dis       Date:  1958-03

2.  Present pattern of early syphilis in the Manchester region. II. Imported infection and the prostitute.

Authors:  S M LAIRD
Journal:  Br J Vener Dis       Date:  1957-12
  2 in total
  16 in total

1.  THE EPIDEMIOLOGY OF RHEUMATIC DISEASES.

Authors:  J H KELLGREN
Journal:  Ann Rheum Dis       Date:  1964-03       Impact factor: 19.103

2.  Some current aspects of the epidemiology of gonorrhoea.

Authors:  S M LAIRD
Journal:  Br J Vener Dis       Date:  1963-06

3.  Gonorrhoea in the city of Manchester, 1951-1961.

Authors:  S M LAIRD
Journal:  Br J Vener Dis       Date:  1962-09

4.  Reiter's Syndrome in father and son.

Authors:  K R GOUGH
Journal:  Ann Rheum Dis       Date:  1962-09       Impact factor: 19.103

5.  Reactions to antibiotics. Their importance in venereology.

Authors:  R R WILLCOX
Journal:  Br J Vener Dis       Date:  1959-12

6.  The recrudescence of venereal diseases.

Authors:  C S NICOL
Journal:  Br Med J       Date:  1961-02-18

7.  The problem of gonorrhoea in England and Wales.

Authors:  A J KING; C S NICOL
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

8.  The problem of gonorrhoea with special reference to England and Wales.

Authors:  A J KING; C S NICOL
Journal:  Br J Vener Dis       Date:  1961-06

9.  Sexual attitudes, preferences and infections in Ancient Greece: has antiquity anything useful for us today?

Authors:  R S Morton
Journal:  Genitourin Med       Date:  1991-02

10.  Epidemiological aspects of gonococcal infections.

Authors:  R R WILLCOX
Journal:  Bull World Health Organ       Date:  1961       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.